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1. INTRODUCTION  
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Diabetes and hypertension are important causes of mortality, morbidity, and health-
system costs in the world. These diseases due to their chronic nature require a high degree of 
self-monitoring and -administration of treatment from the patient, leading to suboptimal levels 
of adherence to the treatment regimen. 
 
1.1. Definition of adherence 
The WHO defines adherence as: "The extent to which the patient’s behavior – taking 
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider." (1).  
 
1.2. Importance of adherence 
The term "adherence" is the preferred term today compared to "compliance" which 
was used most often in the past. Compliance is associated with a paternalistic role of the 
treating health professional, in the sense of not following the drug regimen prescribed by the 
doctor, whereas adherence is based on the therapeutic alliance between patient and treating 
physician and thus explicitly refers to responsibilities on both sides. The main goal of any 
prescribed medical therapy is to reach a certain desired outcome in the patient. In order to 
achieve this desired result many therapies require a certain degree of self-management of the 
patient. Adherence to the therapy is not restricted to the patient taking his medication but also 
often includes other demanding factors like sticking to a diet, exercising and making life style 
changes in general (2). 
Good adherence to a beneficial drug therapy is associated with reduced mortality 
compared to poor adherence (3). 
Problems with adherence are observed in all situations where the self-administration 
of treatment is required, regardless of type of disease, disease severity and accessibility to 
health resources. Especially in chronic diseases patients experience difficulties to stick to their 
recommended regimens with an estimated adherence rate of 40-50% (compared with 70-80% 
for short term therapy).  This leads to suboptimal disease control, causes medical and 
psychosocial complications of disease, reduces patients’ quality of life, and wastes health care 
resources. Poor adherence is the primary reason for suboptimal clinical benefit (1,2). 
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1.3. Factors influencing adherence 
A large number of studies have been conducted over the years to find out factors that 
can have an impact on adherence. A systematic review that was published in 2008 searched 
the Medline database from 1970 to 2005 to identify relevant factors relating to therapeutic 
adherence. They found numerous factors and they are somewhat intertwined with each other, 
however they can be subdivided into five main categories: patient-centered factors, therapy-
related factors, social and economic factors, healthcare system factors and disease factors (2).  
Patient centered factors include demographic factors like age, ethnicity, gender, 
education and marriage status and psychosocial factors like beliefs, motivation and attitude. 
Furthermore, patient centered factors are composed of the patient-prescriber relationship, 
health literacy, patient knowledge, physical difficulties, tobacco smoking or alcohol intake, 
forgetfulness and a history of good compliance (2). Therapy-related factors consist of the 
route of administration, treatment complexity, the duration of the treatment period, 
medication side effects, the degree of behavioral change required, taste of the medication and 
requirements for drug storage (2). Healthcare system factors are lack of accessibility, long 
waiting time, difficulty in getting prescriptions filled and unhappy clinic visits (2). Social and 
economic factors are comprised of the inability to take time off work, cost and income and 
social support (2). Disease factors are disease symptoms and the severity of the disease (2). 
Of course, these factors differ on the effect they have on adherence, with some of them 
having inconsistent and even contradictory impact. 
 
1.4. Diabetes Mellitus 
Diabetes is a chronic disease characterized by high levels of blood sugar, resulting 
from insufficient insulin secretion, disturbed insulin action, or both. The body needs insulin to 
enable the cells to take up sugar from the blood and use it as an energy source or to convert it 
into fat. If unable to do so, elevated blood sugar levels eventually lead to damage to organs, 
blood vessels and nerves. Diabetes is highly prevalent with 422 million adults living with the 
disease in 2014 worldwide compared to 108 million in 1980. The main causes for this drastic 
increase are considered to be an aging population, poor diet, obesity and a sedentary lifestyle 
(1). 
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1.5. Types of diabetes  
There are three main types of diabetes, Diabetes type 1 and 2 and gestational diabetes. 
Type 1 diabetes is the result of destruction of pancreatic beta cells, which are responsible for 
the production of insulin. The loss of beta cells is most often caused by an autoimmune 
reaction but can also be idiopathic (4). As a result, blood insulin levels are continuously low 
and the blood sugar level increases. The disorder precipitates in genetically susceptible 
individuals presumably triggered by environmental factors like enteroviruses. The genes 
associated with type 1 diabetes include HLA, insulin, PTPN22, IL2Ra, and CTLA4 (4). This 
form of diabetes accounts for only 5–10% of all cases of the disease (5). 
Type 2 diabetes is caused by a combination of resistance to insulin action by the target 
cells and an inadequate compensatory insulin secretory response by the pancreas (5). The 
main factors leading to the disease are excessive body weight and insufficient exercise, but 
there also is a genetic component (6). It is the most prevalent form of the disease accounting 
for about 90% of all cases of diabetes (7). 
Gestational diabetes is hyperglycaemia with onset or recognition during pregnancy. It 
is found in 2–10% of pregnancies and may disappear after delivery. However in 5–10% of 
cases it progresses to diabetes mellitus type 2 (6).  
 
1.6. Complications and burden of disease  
Especially if left untreated or if poorly controlled, diabetes can lead to a series of 
complications including diabetic ketoacidosis, kidney failure, amputations, blindness, heart 
attacks and stroke among many others. According to estimations of the WHO 1.6 million 
deaths annually can be directly attributed to Diabetes. The treatment costs of diabetes amount 
to 825 billion dollars annually worldwide (8). 
 
1.7. Prevention and treatment of diabetes: 
There are no known prevention measures for Diabetes type 1 (6). 
Type 2 diabetes however can often be prevented or at least delayed by a change in 
lifestyle. Consuming a healthy diet, exercising, maintaining a normal body weight and 
avoiding tobacco use all decrease the risk of developing the disease (6). 
Early diagnosis is a key component in the treatment of diabetes. The longer a person 
lives with untreated diabetes the poorer the outcome is likely to be (9). 
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The main goal of diabetes treatment is to maintain the blood sugar at physiologic 
levels, thus avoiding acute complications like hypo- and hyperglycemia and chronic 
complications like heart disease (10).   
In Type 1 diabetes insulin therapy is always required as well as dietary changes 
and exercise (11). 
Type 2 diabetes may be managed with insulin, weight reduction, dietary changes and 
non-insulin medications like the oral hypoglycaemic agent metformin (12). 
Most patients with type 2 diabetes are not able to control their blood sugar level with 
diet and exercise alone and require the introduction of pharmacotherapy. At this point a 
monotherapy with an oral hypoglycaemic agent is commonly introduced. In the case that the 
blood sugar control is still not effective enough or due to progression of the disease, more 
medications can be added as part of a polytherapy regimen. As a last step injectable 
treatments are introduced (13).  
Regular screenings for retinopathy and kidney disease, blood lipid control and foot 
care are also helpful methods of reducing both complications and costs of treatment (9). 
HbA1c can be used as an indicator for both the management of diabetes and as a predictor for 
the clinical outcomes. 
 
1.8. Adherence in diabetes 
The proper treatment of diabetes requires a lot from the patient. Taking medicine, self-
monitoring of blood sugar, sticking to dietary restrictions, regular foot care, exercise and 
ophthalmic examinations are important parts of the treatment regimen (1). 
Due to non-compliance with these factors only 28% of patients treated for diabetes in 
Europe achieved good glycemic control (14). This makes poor adherence to recognized 
standards of care the main cause of development of complications of diabetes and their 
associated costs (1). 
Studies show that there is a poor correlation between the adherence to different 
components of the treatment regimen (15). Because of this we will analyse the different 
treatment components separately. 
 
 1.8.1. Monitoring of glucose  
There are two available methods, self-monitoring of blood glucose (SMBG) and 
continuous glucose monitoring (CGM). Glucose monitoring is an important part of diabetes 
management and a key component in the prevention of diabetes related complications. It 
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helps patients to maintain healthy blood sugar levels and to recognize and correct abnormal 
values (16). A study of children and adolescents with type 1 diabetes showed that increased 
number of SMBG checks in the range of 0 to 5 daily was significantly associated with 
reduced HbA1C (17). 
For patients on insulin therapy the American Diabetes Association Practice Guidelines 
recommend using SMBG prior to meals and snacks, postprandially, at bedtime, before 
exercise, when they suspect low blood glucose, after treating low blood glucose, and prior to 
critical tasks such as driving (18). This usually results in 6–10 checks per day (19). 
A large study found SMBG adherence rates to be as low as 44% for adults with T1DM 
and 24% for adults with T2DM (16). 
 
1.8.2. Exercise and Diet  
The adherence to treatment recommendations for exercise and diet is very difficult to 
assess. This is because of the individuality of treatment plans.  
An appropriate diet can be a powerful method to prevent and reverse diabetes type 2 
(20). 
A Canadian cross sectional study with 80 participants with type 2 diabetes found an 
overall good adherence but overall daily intakes of sodium and saturated fat exceeded the 
nutrition therapy guidelines that were used (21). 
Physical activity is considered an important intervention to achieve good glycaemic 
control in Type 2 diabetes. However adherence to long-term exercise programs varies widely 
between 10% and 80% (22). 
 
1.8.3. Oral hypoglycemic agents (OHAs) 
Studies have proved that there is an inverse relationship between taking a prescribed 
oral hypoglycemic agent and the HbA1c level (23). Adherence to OHA therapy ranged from 
36% to 93% in an analysis of 11 retrospective studies (13). No difference in compliance was 
found for patients exclusively on OHA therapy whether they were on monotherapy or on 
combination therapies with various OHAs (24). 
 
1.8.4. Insulin   
Non-adherence to insulin is associated with increased mortality. In retrospective 
insulin studies in subjects with type 2 diabetes the non-adherence rates ranged from 20% to 
38% (25). 
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A study of 1,099 patients with type 2 diabetes in Scotland found the highest 
compliance among patients taking only insulin with 67%. The lowest compliance was 39% in 
patients taking insulin together with an oral hypoglycemic agent (13). 
 
1.9. Hypertension 
Hypertension or high blood pressure is a long term medical condition characterized by 
an elevated pressure in the vascular system. In adults it is defined as either systolic or diastolic 
blood pressure that is consistently higher than a predetermined value (usually 130–140/90 
depending on the guidelines (26)). It is usually asymptomatic but is a serious risk factor for 
cardiovascular disease.  
The prevalence of the disease is continuously rising with 1 billion living with the 
condition in 2008 compared to 600 million in 1980 (6). Due to this high number of affected 
individuals, hypertension is a huge contributor to the burden of disease and to heath care 
costs. It is estimated that 9.4 million deaths annually can be attributed to high blood pressure, 
including 45% of deaths due to heart disease and 51% of all terminal stroke cases (6). This 
makes hypertension the leading global risk factor for mortality in the world (27). 
 
1.10. Types of hypertension 
Hypertension is classified as either primary or secondary. 90–95% of cases are 
primary hypertension, caused by nonspecific lifestyle and genetic factors. The most common 
risk factors are increased salt intake, high BMI, smoking and alcohol consumption (28,29), 
(30). Secondary hypertension is high blood pressure due to an identifiable cause 
like endocrine diseases, kidney diseases, and tumors, or as a side effect of medications (31). 
 
1.11. Treatment of hypertension 
The goal of hypertension treatment is to lower increased blood pressure in order to 
protect the patient from complications like heart disease, stroke and vascular disease. The 
target blood pressure usually ranges between 140–160/90–100 mmHg for the general 
population (32). 
 
1.11.1. Non-pharmacological management 
Life style changes are an important part in the treatment of hypertension and should be 
the initial approach to hypertension management. In some cases of increased blood pressure, a 
change in diet, physical exercise, weight loss and stress management might be the only 
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treatment necessary. Even when the treatment requires the use of medication these changes 
are still beneficiary and recommended. Dietary changes include reducing salt and increasing 
potassium intake and avoiding alcohol (33). 
A randomized controlled trial of 459 adults showed that the DASH diet, a diet rich in 
fruits, vegetables, and low-fat dairy foods with reduced intake of saturated fats, total fat, and 
cholesterol, significantly reduced both systolic and diastolic blood pressure (34).  
 
1.11.2. Medications 
There are various pharmaceutical agents available for the treatment of high blood 
pressure. The first line medications include thiazide diuretics, beta-blockers, dihydropyridine 
calcium channel blockers (CCB), angiotensin converting enzyme (ACE) inhibitors and 
angiotensin receptor blockers (ARB). They can be used as monotherapy or polytherapy. For 
most patients however one medication is not enough to control their hypertension (35). 
 
1.12. Adherence in hypertension 
More than 50% of patients being treated for hypertension drop out of care completely 
within a year of diagnosis. Of those continuing with treatment only about 50% take at least 
80% of their prescribed medications. This amounts to about 75% of patients with diagnosed 
hypertension not achieving optimum blood-pressure control because of poor adherence (1). 
A meta-analysis of 21 randomized controlled studies investigating measures of 
promoting adherence in antihypertensive therapy using different approaches showed an 
improvement in adherence in 13 studies or 60% of patients. Out of these 13 randomized 
controlled trials with significantly improved adherence, 12 showed additional significant 
positive effects on antihypertensive treatment end results (36). 
 
1.12.1. Life style changes 
A study that tried to assess the prevalence of adherence to self-management activities 
among hypertensive patients in terms of adherence to antihypertensive medications and 
lifestyle modifications found the overall adherence to be only 23%. This included diet, 
exercise, smoking cessation, and moderation of alcohol consumption (37). However, 
adherence to the different factors varies widely between different countries. This could be 
explained with the large differences in habits and behaviors across the globe (1). 
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1.12.2. Diet 
Dietary adherence was only 22.5% in a study of 400 hypertensive patients. The most 
important negative predictors were peer influence, social gatherings, lack of support and lack 
of belief in the effectiveness of dietary treatment. The most effective way to increase 
adherence was found to be counseling (38). 
 
1.12.3. Exercise 
Adherence to exercise recommendations range between 31 to 51.9%. The English 
longitudinal study of aging found that participants with reported hypertension have lower 
physical activity levels compared to normotensive participants (39). 
 
1.12.4. Pharmacotherapy 
Adherence to pharmacotherapy for hypertension ranges between 50 and 70% 
depending on duration of follow-up, methods of assessment of adherence, drug regimens used 
in different studies and differences among the studied population. The WHO estimates that 
between 16 to 50% of patients with hypertension discontinue their antihypertensive 
medications within the first year of treatment and among those who continue their therapy in 
the long term, missed doses of medication are common. Good adherence with prescribed 
antihypertensive medication has been associated with improved blood pressure control and a 
risk reduction for stroke (30–43%) and myocardial infarction (15%) while suboptimal 
adherence is the main factor contributing to the burden of uncontrolled hypertension (1). 
Studies have shown that measures to simplify medication therapy schemes, for 
example reducing the number of pills taken per day, are the most effective single measures to 
improve adherence. Combination therapy has been proofed to have a better efficacy and 
tolerability compared to monotherapy while suboptimal treatment tolerability profile and a 
high pill burden negatively affect adherence. Current hypertension treatment guidelines 
recommend fixed‐dose combination therapy to provide well‐tolerated and efficacious 
antihypertensive therapy with a low pill burden (40). 
In our study we will try to identify characteristics that lead to better adherence in a 
large population-based sample from Dalmatia, namely in the populations of Vis, Korčula and 
Split. Additionally, our goal is to provide an overview of the proportion of individuals with 
undiagnosed diabetes or hypertension and those with known but poorly controlled disease.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. AIMS AND HYPOTHESES
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2.1. Aims 
The aim of this study was to identify individuals with undiagnosed 
diabetes/hypertension and those with known but poorly controlled diabetes/hypertension in a 
large population-based sample from Dalmatia. We further tried to determine characteristics 
and traits that were associated with a higher degree of adherence.  
 
 2.2. Hypotheses 
1. Older age, male gender, a lesser degree of education and lower subjective material 
status are associated with poorly controlled diabetes/hypertension. 
2. Subjects living on the islands of Korčula and Vis are more likely to have undiagnosed 
diabetes/hypertension than subjects living in the city of Split.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. MATERIALS AND METHODS
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This study was based on a subsample of the 10,001 Dalmatians project, which is the 
largest research-oriented biobank in Croatia. The main objective of this program is to create a 
comprehensive resource for the study of genetic, environmental and social determinants of 
health and diseases with emphasis on chronic diseases, which are the leading cause of death in 
Croatia and other developed countries (41). 
 
 
3.1. Subjects 
For the purpose of this study, we accessed the data of all subjects recruited in the 
islands of Vis and Korčula, as well as those from the city of Split (Figure 1). The recruitment 
scheme was based on nearly systematic invites of the island populations (for the islands 
Korčula and Vis), while subjects from the city of Split were recruited in convenient sampling, 
aiming to reach a sample size of a thousand, and serving as the mainland control for the island 
populations.  
  
Figure 1. The map of the 10,001 Dalmatians project sites 
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3.2. Measurements 
The assessment of blood pressure was based on two measurements in the sitting 
position, after at least 10 minutes of resting. The two measurements were then entered into the 
analysis, but the final blood pressure value was based on the double weighting of the second 
measurement (systolic, measurement1+ systolic, measurement2+ systolic, measurement2)/3. 
The cut-off values were set at 140 mmHg for systolic and 90 mmHg for diastolic blood 
pressure. In addition, all subjects who had a medical history of hypertension or were taking 
any of the hypertension-related medication were also considered to be hypertensive.  
In a similar way, all subjects who had serum fasting glucose levels over 6.5 mmol/L 
OR had HbA1c levels above this cut-off value were considered to have measured diabetes. In 
addition, we considered all those who had diabetes in their medical records OR were taking 
any diabetes-related medication as those with positive medical records for diabetes. All 
glucose and HbA1c measurements were performed by the accredited laboratory (Salzer or 
Breyer, both located in Zagreb, Croatia). All blood samples were taken after an overnight 
fasting period, into 9 mL EDTA tubes, which were centrifuged in a cooled centrifuge and 
stored at -80°C until the analysis was performed.  
Besides measurements, we also used a few survey-based questions. These were related 
to socioeconomic status. A total of four variables were used – a subjective perception of the 
individual socioeconomic status, objective perception (measured by the amount of HRK that 
the person earns per month), years of schooling (number of completed classes) and material 
index, a composite index of 16 variables that was developed for the purpose of assessing this 
population. 
 
 
3.3. Classification 
The classification above allowed us to classify all the subjects into four groups: (a) 
diagnosed, properly treated, (b) diagnosed, improperly treated, (c) incident - newly diagnosed 
and (d) healthy - undiagnosed. In the similar pattern as the contingency table, options (a) and 
(d) were considered as reference points, while (b) and (c) were considered as indicators of 
problems in health care, as both options should ideally be set at zero value. Option c indicates 
failure to properly diagnose diseased individuals, while option b indicates failure of the health 
system (or subject) to properly manage their disease. Both of these classifiers were used as the 
primary outcome variable, and they were the focus of this thesis.    
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3.4. Statistical analysis 
The statistical analysis was based on descriptive and analytic methods. The numerical 
variables were reported as means and standard deviations, while categorical ones were based 
on absolute numbers and percentages. Analysis of variance was used in the numeric data 
analysis for three cohorts. Chi-square test was used in the analysis of categorical variables, 
either with one or two degrees of freedom, depending on the number of analysed groups. 
Logistic regression model was used in the final analytic step, in order to allow the 
multivariate model development, encompassing multiple inputs and allowing for the 
simultaneous estimation of their effect. All analyses were performed using SPSS v 21 (IBM 
SPSS, Armonk, NY, USA), with significance set at P<0.050.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. RESULTS
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This study encompassed a total of 4,851 subjects, from three cohorts of the 10.001 
Dalmatians – the islands of Vis and Korčula and the coastal city of Split (Table 1). There 
were significant differences between the cohorts, indicating a higher share of men and an 
older average age in the Vis sample, and generally a better socio-economic status in Split 
(Table 1).  
 
Table 1. Three samples breakdown according to the basic demographic variables 
Variable* Vis 
(n=1,029) 
Korčula 
(n=2,782) 
Split 
(n=1,012) 
P 
Sex/Men; n (%) 427 (41.5) 1,023 (36.8) 395 (39.0) 0.012 
Age (years) 55.76±15.57 54.20±15.81 50.28±14.42 <0.001 
Years of education 9.99±3.59 10.94±3.22 13.14±3.01 <0.001 
Social status, subjective 3.02±0.77 3.13±0.70 3.33±0.70 <0.001 
Social status, objective n/a 3.32±1.42 4.25±1.42 <0.001 
Material status, index 9.45±2.74 10.24±2.65 11.30±2.46 <0.001 
*Expressed as mean ± standard deviation 
 
The initial analysis of blood pressure and diabetes in the three cohorts indicated 
widespread significant differences, with a generally better situation in Split and a worse 
situation in Vis (Table 2). Interestingly, the prevalence of diabetes in medical records did not 
show significant difference across the three cohorts (Table 2).  
 
Table 2. Prevalence of hypertension and diabetes across cohorts 
Variable; n (%) Vis 
(n=1,029) 
Korčula 
(n=2,782) 
Split 
(n=1,012) 
P 
Hypertension, medical records 354 (34.4) 944 (33.6) 263 (26.0) <0.001 
Hypertension, measured 465 (45.2) 901 (32.1) 282 (27.9) <0.001 
Diabetes, medical records 67 (6.5) 143 (5.1) 45 (4.4) 0.093 
Diabetes, measured 169 (16.4) 442 (15.7) 78 (7.7) <0.001 
 
The analysis of the measured vs. diagnosed hypertension suggested that 14.4% of all 
subjects could be classified as incident (new) cases (Table 3). When taken within the 
diagnosed hypertension group, 60.8% of all subjects (949/1,561) were improperly treated 
(Table 3). The breakdown according to cohort indicated that Vis had the highest share of 
incident cases (19.4%) followed by Split (13.1%) and Korčula (13%) (Table 3) with the 
prevalence of incident cases being significantly higher in Vis (Chi-square=25.79; P<0.001). 
The prevalence of improperly treated subjects across cohorts showed a similar distribution 
with 74.9% in Vis, 56.7% in Korčula and 56.7% in Split (Chi-square=38.0; P<0.001, with 
significant difference driven by Vis vs. Korčula and Split).   
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Table 3. The analysis of measured vs. diagnosed hypertension 
 Diagnosed hypertension 
(medical history OR use 
of hypertension-related 
medication) 
 
Yes No Total 
Measured hypertension (BP over 140 mmHg for 
systolic OR 90 mmHg for diastolic); n (%-total), 
entire sample 
Yes 949  
(19.6) 
699  
(14.4) 
1,648 
No 612  
(12.6) 
2,590  
(53.4) 
3,202 
 Total 1,561 3,289 4,850 
Measured hypertension (BP over 140 mmHg for 
systolic OR 90 mmHg for diastolic); n (%-total), Vis 
Yes 265 (25.8) 200 (19.4) 465 
No 89 (8.6) 475 (46.2) 564 
 Total 354 675 1029 
Measured hypertension (BP over 140 mmHg for 
systolic OR 90 mmHg for diast.); n (%-total), 
Korčula 
Yes 535 (19.0) 366 (13.0) 901 
No 409 (14.5) 1,501 (53.4) 1,910 
 Total 944 1867 2,811 
Measured hypertension (BP over 140 mmHg for 
systolic OR 90 mmHg for diastolic); n (%-total), 
Split 
Yes 149 (14.7) 133 (13.1) 282 
No 114 (11.3) 616 (60.9) 730 
 Total 263 749 1,012 
 
The analysis of diabetes in general had a similar pattern, but with even more 
inadequately treated subjects – 80% of diagnosed cases were inadequately treated (Table 4). 
Overall 10.6% of subjects were incident cases, with a significantly better situation in Split 
with 4.4% (Chi-square=47.91; P<0.001) and comparable percentages in Vis (12%) and 
Korčula (12.2%) (Table 4). The prevalence of improperly treated subjects across cohorts was 
79.1% in Vis, 81.1% in Korčula and 77.8% in Split (Chi-square=0.28; P=0.987). 
 
Table 4. The analysis of measured vs. diagnosed diabetes 
 Diagnosed diabetes 
(medical history OR use 
of diabetes-related 
medication) 
 
Yes No Total 
Fasting serum glucose over 6.5 mmol/L OR HbA1c 
greater than 6.5%; n (%-total), entire sample 
Yes 204  
(4.2) 
485  
(10.0) 
689 
No 51  
(1.0) 
4,110  
(84.7) 
4,161 
 Total 255 4,595 4,850 
Fasting serum glucose over 6.5 mmol/L OR HbA1c 
greater than 6.5%; n (%-total), Vis 
Yes 53 (5.2) 116 (11.3) 169 
No 14 (1.4) 846 (82.2) 860 
 Total 67 962 1,029 
Fasting serum glucose over 6.5 mmol/L OR HbA1c 
greater than 6.5%; n (%-total), Korčula 
Yes 116 (4.1) 326 (11.7) 442 
No 27 (1.0) 2,342 (83.3) 2,369 
 Total 143 2,668 2,811 
Fasting serum glucose over 6.5 mmol/L OR HbA1c 
greater than 6.5%; n (%-total), Split 
Yes 35 (3.5) 43 (4.2) 78 
No 10 (1.0) 924 (91.3) 934 
 Total 45 967 1,012 
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The regression model for prediction of the incident cases of hypertension suggested 
strong cohort-based differences, with the highest odds in Vis (Table 5). The same model 
indicates strong age-related risk increase, with a significant effect from the years of education 
– higher education was associated with reduced risk of becoming an incident case (Table 5). 
The model explained 14.7% of variance. The improperly treated hypertension model indicated 
even stronger cohort effect, again with Vis as the worst cohort, and comparable risks in 
Korčula and Split (Table 5). There was no strong age-related effect and no statistically 
significant effect regarding education. The percent of variance regarding improperly treated 
hypertension was 5.5%, amounting to a third of the variance from the incident hypertension 
model (Table 5).  
 
Table 5. The logistic regression model predicting incident and improperly treated 
hypertension 
 Incident hypertension Improperly treated hypertension 
 P OR (95% CI) P OR (95% CI) 
Cohort     
Vis (referent) <0.001 1.00 <0.001 1.00 
Korčula <0.001 0.67 (0.54-0.83) <0.001 0.48 (0.36-0.63) 
Split 0.033 0.74 (0.56-0.98) 0.001 0.55 (0.38-0.79) 
Age group     
18-34 (referent) <0.001 1.00 0.003 1.00 
35-64 <0.001 4.21 (2.94-6.02) 0.354 1.57 (0.61-4.08) 
65+ <0.001 12.79 (8.60-19.03) 0.092 2.29 (0.87-5.98) 
Years of education <0.001 0.93 (0.90-0.96) 0.169 0.98 (0.94-1.01) 
Material status, subjective 0.328 0.93 (0.81-1.07) 0.989 1.01 (0.86-1.17) 
Material status, indicator 0.128 1.03 (0.99-1.07) 0.284 0.98 (0.93-1.02) 
R2; % 14.7 5.5 
R2 – percent of variance explained by the model 
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The logistic regression model predicting incident and improperly treated diabetes 
indicated different findings. There were no statistically significant differences between Vis 
and Korčula, while living in Split was associated with a reduced risk of being incidentally 
diagnosed with diabetes (OR: 0.50; 95% CI: 0.34-0.74) (Table 6). Both years of education 
(OR: 0.92; 95% CI: 0.89-0.95) and subjective estimate of material status (OR: 1.19; 95% 
CI:1.03-1.38) were significant predictors for incident diabetes, suggesting that it was more 
likely to be developed by those with lower education and higher socio-economic status (Table 
6). Improperly treated diabetes had equal odds between all three cohorts, but was more likely 
to be developed by the middle-age group (OR: 6.73; 95% CI: 1.20-37.74) (Table 6). 
Interestingly, no other variables reached significance in this model. Similar to the 
hypertension model, the percent of variance for incident diabetes cases was about three times 
higher than for improperly treated diabetes.  
 
Table 6. The logistic regression model predicting incident and improperly treated diabetes 
 Incident diabetes Improperly treated diabetes 
 P OR (95% CI) P OR (95% CI) 
Cohort     
Vis (referent) <0.001 1.00 0.659 1.00 
Korčula 0.210 1.17 (0.92-1.48) 0.958 1.02 (0.48-2.17) 
Split <0.001 0.50 (0.34-0.74) 0.449 0.67 (0.24-1.88) 
Age group     
18-34 (referent) <0.001 1.00 0.092 1.00 
35-64 <0.001 8.39 (3.93-17.89) 0.030 6.73 (1.20-37.74) 
65+ <0.001 16.25 (7.53-35.08) 0.063 5.14 (0.92-28.83) 
Years of education <0.001 0.92 (0.89-0.95) 0.738 1.02 (0.92-1.12) 
Material status, subjective 0.020 1.19 (1.03-1.38) 0.095 1.57 (0.93-2.68) 
Material status, indicator 0.945 1.00 (0.96-1.05) 0.966 1.00 (0.86-1.16) 
R2; % 11.2 4.8 
R2 – percent of variance explained by the model 
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The results of this study show alarmingly high percentages of patients with 
hypertension and diabetes that are being improperly treated – 60.8% of patients with 
hypertension had elevated blood pressure levels at measurement, while 80% of people with 
diagnosed diabetes had elevated levels of HbA1c, suggesting the need for a systematic 
intervention across health care. 
A study conducted in 2011-2012 in the US found every third adult to have high blood 
pressure. Nearly half (48.2%) of these subjects had poorly controlled hypertension. More than 
a third (36.2%) of those affected were not aware of their condition (42). Another study 
revealed that globally almost half (45.8%) of all diabetes cases in adults remain undiagnosed. 
Most of those cases (83.8%) were found in low and middle income countries (43).  
Our findings regarding improperly treated hypertension were more pronounced in the 
island Vis with 74.9% of subjects with medical records of hypertension still having high 
blood pressure during our measurements, while in Split and Korčula this number only 
amounted to 56.7%. The situation with incident cases was better overall, only about 14% of 
all subjects could be considered as incident cases for hypertension and 10% for diabetes. 
However, our study revealed significant differences between the cohorts, Vis again in front 
with 19.4% of incident cases of hypertension compared to 13.1% in Split and 13% in Korčula. 
In the section of incident cases of diabetes Split achieved by far the best result with only 4.4% 
compared to 12% in Vis and 12.2% in Korčula. Interestingly, the numbers seemed to be 
nearly equally distributed throughout the cohorts in the case of improperly treated diabetes. 
In order to uncover why the population of Vis had the highest numbers in regard to 
both incident cases and improperly treated cases of hypertension we must assume that age 
might have been a confounding factor. Furthermore, the studied population from Vis had the 
highest proportion of men, so supposedly sex was also a confounder. Numerous papers have 
found gender differences in incident cases of hypertension and diabetes. For example, a study 
from 2015 found that male subjects under 65 years of age had higher levels of hypertension 
compared to women of the same age. This was believed to have both biological and 
behavioral reasons (44). Another paper studying the age-related differences in 
antihypertensive medication adherence found a negative correlation between recent poor 
physical health and adherence (45). 
The cohort-based differences revealed in our study are surely one of the things that 
requires more attention, especially having in mind the preamble of the Croatian health care 
laws, which aim to provide equal level of care for all people (46).  
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Admittedly, our figures are almost certainly an overestimation, as the patients could 
have had "white coat" syndrome or could have misreported being fasting at blood sample 
taking, suggesting that the real number of incident cases is probably lower than our results 
imply.  
Interestingly, the percentages of variance explained by the model were about three 
times higher for both hypertension and diabetes in the incident model compared to the 
improperly treated model. These findings suggest that internal variables, such as years of 
education or socioeconomic status have more effect on the incident cases, while other external 
variables have more effect on improper treatment. This indirectly shows that the burden of 
improperly treated patients is more in the domain of health care than the individual. 
Our model is admittedly over-simplified, but it suggests that the intervention towards 
incident cases should be population-based, while the improvement of the share of properly 
treated patients should be sought within the health care system itself. There is a need for 
further research to be conducted in order to identify system related factors that affect 
adherence. 
The limitations of this study include a set of rather narrow data, lack of information on 
the GP, which could have explained a lot more variance due to possible differences between 
them. A retrospective cohort study with 6436 patients found great discrepancies in adherence 
to therapy depending on the treating physician, suggesting a link between health providers 
and patient adherence (47). Also, we are lacking a number of possible confounders, including 
disease-related behaviours, coping mechanisms, locus of control or similar estimates of 
behaviour.  
Nevertheless, these results suggest the need for a substantial improvement of this 
situation, having in mind that hypertension and diabetes are two main chronic diseases that 
increase cardiovascular and all-cause morbidity and mortality.  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. CONCLUSION
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1. The probability of having improperly treated hypertension was lower among 
examinees from Korčula and Split compared to Vis.  
2. Subjects from Vis were the oldest and had the highest proportion of male examinees. 
3. Vis inhabitants had the least years of education, lowest subjective social status and 
lowest material status.  
4. Our results suggest a positive correlation between incident cases of diabetes and 
hypertension and living on Vis, older age and less years of education.  
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Objectives: The aim of this study was to identify individuals with undiagnosed 
diabetes/hypertension and those with known but poorly controlled diabetes/hypertension in a 
large population-based sample from Dalmatia. We further tried to determine characteristics 
and traits that were associated with a higher degree of adherence.  
Materials and Methods: We accessed the data of all subjects recruited in the islands of Vis 
and Korčula, as well as those from the city of Split. The subjects were classified into four 
groups: (a) diagnosed, properly treated, (b) diagnosed, improperly treated, (c) incident - newly 
diagnosed and (d) healthy - undiagnosed. The statistical analysis was based on descriptive and 
analytic methods. Analysis of variance was used in the numeric data analysis for three 
cohorts. Chi-square test was used in the analysis of categorical variables. Logistic regression 
model was used in the final analytic step. All analyses were performed using SPSS v 21 with 
significance set at P<0.050.  
Results: We found 14.4% of all subjects to be incident cases for hypertension. Within the 
diagnosed hypertension group, 60.8% of subjects were improperly treated. 80% of diagnosed 
diabetes cases were inadequately treated. 10.6% of subjects were found to be incident cases 
for diabetes. The regression model for prediction of the incident cases of hypertension 
revealed strong cohort-based differences, with the highest odds in Vis. We further found a 
strong age-related risk increase, with a significant effect from the years of education – higher 
education was associated with reduced risk of becoming an incident case. The improperly 
treated hypertension model indicated even stronger cohort effect, again with Vis as the worst 
cohort. Regarding diabetes there were no significant differences between Vis and Korčula, 
while living in Split was associated with a reduced risk to be an incident case (OR: 0.50). Our 
results suggest that those with lower education and higher socio-economic status were more 
likely to develop diabetes. Improperly treated diabetes was more likely to be developed by the 
middle-age group. 
Conclusion: The probability of having improperly treated hypertension was lower among 
examinees from Korčula and Split compared to Vis. Our results suggest a positive correlation 
between incident cases of diabetes and hypertension and living on Vis, older age and less 
years of education. 
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Naslov: Suradljivost bolesnika s dijabetesom i hipertenzijom 
Ciljevi: Cilj ovog istraživanja bio je prepoznati osobe s dijagnozom šećerne bolesti ili 
povišenog krvnog tlaka te utvrditi jesu li one primjereno ili neprimjereno liječene. Dodatan 
cilj bio je istražiti obilježja ispitanika koji se pridržavaju svoje terapije i dobro kontroliraju 
bolest s onima koji imaju znakove bolesti unatoč korištenju terapije.  
Materijali i metode: Korišteni su podatci ispitanika iz projekta 10.001 Dalmatinac, i to s 
otoka Visu i Korčule, kao i iz grada Splita. Ispitanici su bili svrstani u četiri skupine: (a) 
prisutna dijagnoza, bez znakova akutne bolesti, (b) prisutna dijagnoza, prisutni znakovi 
bolesti, (c) novodijagnosticirani slučaj te (d) zdravi ispitanici. Krvni tlak je mjeren dva puta u 
sjedećem položaju nakon 10 minuta odmora, a kao granične vrijednosti korištene su 140 
mmHg za sistolički i 90 mmHg za dijastolički krvni tlak. Ispitanici sa serumskom razinom 
glukoze iznad 6,5 mmol ili razinom HbA1c iznad ove granične vrijednosti su bili svrstani u 
skupinu bolesnika sa šećernom bolesti. Statistička analiza temeljila se na opisnim i 
analitičkim metodama. Korišteni su hi-kvadrat, analiza varijance i logistička regresija. Sve 
analize provedene su korištenjem SPSS v 21 s razinom značajnosti postavljenom na P <0,050. 
Rezultati: 14,4% svih ispitanika su bili novodijagnosticirani slučajevi povišenog krvnog 
tlaka. Među njima, neprimjereno je bilo liječeno čak 60,8%. Za šećernu bolest taj postotak bio 
je i veći -  čak 80% bolesnika nije imalo primjerene rezultate mjerenja razine šećera u krvi. 
Utvrđeno je da 10,6% ispitanika predstavlja incidentne slučajeve. Regresijski model za 
predviđanje incidentnih slučajeva hipertenzije pokazao je izrazite razlike među analiziranim 
populacijama, s najvećim rizikom na otoku Visu. Dob je bila važan prediktor modela, kao i 
razina obrazovanja. Model za šećernu bolest nije ukazivao na postojanje razlika među 
analiziranim pod-skupinama.  
Zaključci: Rezultati ovog istraživanja pokazuju izražene razlike među analiziranim pod-
skupinama i stvaraju osnovicu za izradu javnozdravstvene intervencije. 
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